– July 1, 2001
July 1, 2001
View Issues
-
Peptide-pulsed Peripheral Blood Mononuclear Cells plus IL-12 as a Melanoma Vaccine
-
Molecular Predictors of Survival After Adjuvant Chemotherapy for Colon Cancer
-
Treatment of Metastatic Renal Cell Carcinoma with High-Dose Bolus IL-2 in a Non-Intensive Care Unit
-
Zoledronic Acid: Better Than Pamidronate?
-
Soluble IL-2 Receptor: A Prognostic Indicator in Head and Neck Cancer
-
Full July 1, 2001 Issue in PDF
-
Clinical Briefs in Primary Care